Vandana CPA - Quanterix Corp Chief Officer
| QTRX Stock | USD 12.33 0.14 1.12% |
Executive
Vandana CPA is Chief Officer of Quanterix Corp
| Age | 50 |
| Address | Building 1, Billerica, MA, United States, 01821 |
| Phone | 617 301 9400 |
| Web | https://www.quanterix.com |
Quanterix Corp Management Efficiency
The company has return on total asset (ROA) of (0.0782) % which means that it has lost $0.0782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1148) %, meaning that it created substantial loss on money invested by shareholders. Quanterix Corp's management efficiency ratios could be used to measure how well Quanterix Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to rise to -0.12 in 2024. At this time, Quanterix Corp's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 4.6 M in 2024, whereas Total Assets are likely to drop slightly above 245.1 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hisham Shiblaq | Procept Biorobotics Corp | 48 | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Patrik Jeanmonod | Cytek Biosciences | 57 | |
| Michael Pisetsky | Si Bone | 46 | |
| Jennifer Englund | CVRx Inc | N/A | |
| CPA CFA | MaxCyte | 55 | |
| Stacey Porter | Procept Biorobotics Corp | 48 | |
| Kimberly Bambach | Tivic Health Systems | 53 | |
| Brent Moen | Tactile Systems Technology | 57 | |
| Amy Treadwell | Neuropace | N/A | |
| Mark Karshner | Orthopediatrics Corp | N/A | |
| Bijesh Chandran | Procept Biorobotics Corp | N/A | |
| Sean Wirtjes | Rapid Micro Biosystems | 55 | |
| Kelley Nicholas | Neuropace | N/A | |
| Elaine Birkemeyer | Tactile Systems Technology | N/A | |
| William George | Electromed | 75 | |
| Deina Walsh | Bone Biologics Corp | 60 | |
| Tom Huang | Sight Sciences | N/A | |
| Ronald CPA | MaxCyte | 66 | |
| MSc MD | CVRx Inc | N/A | |
| Reay MD | Sight Sciences | N/A | |
Management Performance
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0782 |
Quanterix Corp Leadership Team
Elected by the shareholders, the Quanterix Corp's board of directors comprises two types of representatives: Quanterix Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quanterix. The board's role is to monitor Quanterix Corp's management team and ensure that shareholders' interests are well served. Quanterix Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quanterix Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Duffy, CTO, Vice President Research | ||
| Mary Cortizas, VP CRO | ||
| Laurie Churchill, General VP | ||
| Bruce Bal, Vice President - Operations, Service and Quality | ||
| Mark Roskey, Vice President General Manager | ||
| David Walt, Independent Director | ||
| Daniel Pikora, Chief Officer | ||
| Darrin MBA, Senior Officer | ||
| Michael Miller, Chief Officer | ||
| Michael Doyle, Executive Finance | ||
| Naren Bhat, Senior Strategy | ||
| David Panzerella, Vice Sales | ||
| Alexandra Phillips, Senior Officer | ||
| Laurie JD, General VP | ||
| Erica Bell, Chief Officer | ||
| Masoud Toloue, CEO President | ||
| Vandana CPA, Chief Officer |
Quanterix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quanterix Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0782 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 215.93 M | ||||
| Shares Outstanding | 38.38 M | ||||
| Shares Owned By Insiders | 6.54 % | ||||
| Shares Owned By Institutions | 85.32 % | ||||
| Number Of Shares Shorted | 1.99 M | ||||
| Price To Book | 1.41 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quanterix Stock Analysis
When running Quanterix Corp's price analysis, check to measure Quanterix Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quanterix Corp is operating at the current time. Most of Quanterix Corp's value examination focuses on studying past and present price action to predict the probability of Quanterix Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quanterix Corp's price. Additionally, you may evaluate how the addition of Quanterix Corp to your portfolios can decrease your overall portfolio volatility.